MedPath

Text Message Quit Vaping Intervention for Young Adults

Not Applicable
Completed
Conditions
Tobacco Cessation
Registration Number
NCT04251273
Lead Sponsor
Truth Initiative
Brief Summary

This research study, conducted by Truth Initiative, will help us learn how text messaging can help young adults between 18 and 24 years of age quit vaping.

Detailed Description

The Quit Vaping Study (QVS)'s primary aim is to conduct a fully powered comparative effectiveness trial to evaluate the effectiveness of a quit vaping text message program in promoting abstinence from e-cigarettes among young users aged 18-24. This study is a 2-arm randomized controlled trial conducted among young users aged 18-24 recruited through online channels. Participants will be randomized to a quit vaping text message intervention or to an assessment-only control condition and followed for 7 months to roughly correspond to 6-months post-treatment. The secondary aim is to examine potential mediators of program effectiveness, including treatment engagement and changes in self-efficacy and perceived social support for quitting.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2588
Inclusion Criteria
  • Age 18-24
  • Past 30-day use of e-cigarettes containing nicotine
  • Interest in quitting e-cigarette use in the next 30 days
  • US residence
Exclusion Criteria
  • Failure to confirm mobile number after initial sign-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT)7 months post enrollment

Number of participant who responded "No" to the question "In the past 30 days, did you vape at all, even a puff of someone else's?" Denominator is all randomized participants.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Self-reported 7-day Point Prevalence Abstinence (ITT)7 months post enrollment

Number of participants who responded "No" to the question "Have you used any vape, even one puff, in the past 7 days?" Denominator is all randomized participants.

Number of Participants With Self-reported 30-day Point Prevalence Abstinence (Responder Only)7 month post enrollment

Number of participants with who responded 'No" to the question "In the past 30 days, did you vape at all, even a puff of someone else's?" Denominator is participants with responses only.

Number of Participants With Self-reported 7-day Point Prevalence Abstinence (Responder Only)7 months post enrollment

Number of participants who responded "No" to the question "Have you used any vape, even one puff, in the past 7 days?" Denominator is those who responded to the question only.

Trial Locations

Locations (1)

Truth Initiative

🇺🇸

Washington, District of Columbia, United States

Truth Initiative
🇺🇸Washington, District of Columbia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.